These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37681417)

  • 21. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature.
    Alomari S; Zhang I; Hernandez A; Kraft CY; Raj D; Kedda J; Tyler B
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery.
    Brar HK; Jose J; Wu Z; Sharma M
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery.
    Nozhat Z; Heydarzadeh S; Shahriari-Khalaji M; Wang S; Iqbal MZ; Kong X
    Biomater Sci; 2023 Jun; 11(12):4094-4131. PubMed ID: 37073998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models.
    Sandbhor P; Goda J; Mohanty B; Chaudhari P; Dutt S; Banerjee R
    Nanoscale; 2021 Dec; 14(1):108-126. PubMed ID: 34897360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incorporating genomic signatures into surgical and medical decision-making for elderly glioblastoma patients.
    Ene CI; Cimino PJ; Fine HA; Holland EC
    Neurosurg Focus; 2020 Oct; 49(4):E11. PubMed ID: 33002863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymeric nanoparticles for drug delivery in glioblastoma: State of the art and future perspectives.
    Madani F; Esnaashari SS; Webster TJ; Khosravani M; Adabi M
    J Control Release; 2022 Sep; 349():649-661. PubMed ID: 35878729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients.
    Pan E; Mitchell SB; Tsai JS
    J Neurooncol; 2008 Jul; 88(3):353-7. PubMed ID: 18389176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CPP-Based Bioactive Drug Delivery to Penetrate the Blood-Brain Barrier: A Potential Therapy for Glioblastoma Multiforme.
    Mehdipour G; Wintrasiri MN; Ghasemi S
    Curr Drug Targets; 2022; 23(7):719-728. PubMed ID: 35142277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside.
    Li Y; Sharma A; Maciaczyk J; Schmidt-Wolf IGH
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of cell membrane-coated nanoparticles as a novel treatment approach in glioblastoma.
    Allami P; Heidari A; Rezaei N
    Front Mol Biosci; 2022; 9():1083645. PubMed ID: 36660431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-targeting cell-penetrating peptide, p28, for glioblastoma imaging and therapy.
    Mander S; Naffouje SA; Gao J; Li W; Christov K; Green A; Bongarzone ER; Das Gupta TK; Yamada T
    Front Oncol; 2022; 12():940001. PubMed ID: 35936749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug delivery approaches for the treatment of glioblastoma multiforme.
    Fakhoury M
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intranasal delivery in glioblastoma treatment: prospective molecular treatment modalities.
    Morales DE; Mousa S
    Heliyon; 2022 May; 8(5):e09517. PubMed ID: 35647354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor treating fields with radiation for glioblastoma: a narrative review.
    Miller R; Niazi M; Russial O; Poiset S; Shi W
    Chin Clin Oncol; 2022 Oct; 11(5):40. PubMed ID: 36336899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging therapies for glioblastoma: current state and future directions.
    Rong L; Li N; Zhang Z
    J Exp Clin Cancer Res; 2022 Apr; 41(1):142. PubMed ID: 35428347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural products: a hope for glioblastoma patients.
    Vengoji R; Macha MA; Batra SK; Shonka NA
    Oncotarget; 2018 Apr; 9(31):22194-22219. PubMed ID: 29774132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs.
    von Neubeck C; Seidlitz A; Kitzler HH; Beuthien-Baumann B; Krause M
    Br J Radiol; 2015 Sep; 88(1053):20150354. PubMed ID: 26159214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel delivery methods bypassing the blood-brain and blood-tumor barriers.
    Hendricks BK; Cohen-Gadol AA; Miller JC
    Neurosurg Focus; 2015 Mar; 38(3):E10. PubMed ID: 25727219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM).
    Yalamarty SSK; Filipczak N; Li X; Subhan MA; Parveen F; Ataide JA; Rajmalani BA; Torchilin VP
    Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment.
    Tang L; Feng Y; Gao S; Mu Q; Liu C
    Front Pharmacol; 2021; 12():786700. PubMed ID: 34899350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.